Psychosocial factors associated with an increased frequency of prostate cancer screening in men ages 40 to 79 years: The olmsted county study

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 12, 2008, Pages 3588-3592

  Wallner, Lauren P ^a   Sarma, Aruna V ^a   Lieber, Michael M ^b   St Sauver, Jennifer L ^b   Jacobson, Debra J ^b   McGree, Michaela E ^b   Gowan, Monica E ^b   Jacobsen, Steven J ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b MAYO CLINIC   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER SURGERY; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SOCIAL PSYCHOLOGY;

ADULT; AGED; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; MINNESOTA; PHYSICAL EXAMINATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RISK FACTORS;

EID: 57449093383     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0050     Document Type: Article

References (20)

1. Crawford ED. Epidemiology of prostate cancer. Urology 2003;62:3-12.
2. National Cancer Institute. Estimated new cases and deaths of prostate cancer. National Cancer Institute; 2007. Accessed 2007 Jun 18.
3. Consedine NS, Morgenstern AH, Kudadjie-Gyamfi E, Magai C, Neugut AI. Prostate cancer screening behavior in men from seven ethnic groups: the fear factor. Cancer Epidemiol Biomarkers Prev 2006;15:228-37.
4. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990;17:337-47.
5. Jacobsen PB, Lamonde LA, Honour M, Kash K, Hudson PB, Pow-Sang J. Relation of family history of prostate cancer to perceived vulnerability and screening behavior. Psychooncology 2004;13:80-5.
6. Miller SM, Diefenbach MA, Kruus LK, Watkins-Bruner D, Hanks GE, Engstrom PF. Psychological and screening profiles of first-degree relatives of prostate cancer patients. J Behav Med 2001;24:247-58.
7. Kunkel EJ, Meyer B, Daskalakis C, Cocroft J, Jennings-Dozier K, Myers RE. Behaviors used by men to protect themselves against prostate cancer. Cancer Epidemiol Biomarkers Prev 2004;13:78-86.
8. Beebe-Dimmer JL, Wood DP, Jr., Gruber SB, et al. Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study. Urology 2004;63:282-7.
9. Beebe-Dimmer JL, Wood DP, Jr., Gruber SB, et al. Risk perception and concern among brothers of men with prostate carcinoma. Cancer 2004;100:1537-44.
10. Donato F, Bollani A, Spiazzi R, et al. Factors associated with non-participation of women in a breast cancer screening programme in a town in northern Italy. J Epidemiol Community Health 1991;45:59-64.
11. Aro AR, de Koning HJ, Absetz P, Schreck M. Two distinct groups of non-attenders in an organized mammography screening program. Breast Cancer Res Treat 2001;70:145-53.
12. Jacobsen SJ, Jacobson DJ, Girman CJ, et al. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status. J Urol 1999;162:1301-6.
13. Jacobsen SJ, Guess HA, Panser L, et al. A population-based study of health care-seeking behavior for treatment of urinary symptoms. The Olmsted County Study of Urinary Symptoms and Health Status among Men. Arch Fam Med 1993;2:729-35.
14. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-74.
15. Bloom JR, Stewart SL, Oakley-Girvans I, Banks PJ, Chang S. Family history, perceived risk, and prostate cancer screening among African American men. Cancer Epidemiol Biomarkers Prev 2006;15:2167-73.
16. Merrill RM. Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah. Prev Med 2001;33:646-52.
17. Meiser B, Cowan R, Costello A, Giles GG, Lindeman GJ, Gaff CL. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake. Urology 2007;70:738-42.
18. Moran WP, Cohen SJ, Preisser JS, Wofford JL, Shelton BJ, McClatchey MW. Factors influencing use of the prostate-specific antigen screening test in primary care. Am J Manag Care 2000;6:315-24.
19. Odedina FT, Scrivens J, Emanuel A, LaRose-Pierre M, Brown J, Nash R. A focus group study of factors influencing African-American men's prostate cancer screening behavior. J Natl Med Assoc 2004;96:780-8.
20. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 2006;56:11-25.